Innova Captab Limited

INNOVACAP

INE0DUT01020

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 07:49:10 2024-05-14 am EDT			5-day change	1st Jan Change
468.9 ^INR	+1.74%		+2.76%	-13.39%

Mar. 29	Innova Captab Names CFO	MT
Mar. 29	Innova Captab Limited Appoints Lokesh Bhasin as the Chief Financial Officer, Effective March 30, 2024	CI

Innova Captab Limited Announces Resignation of Gaurav Srivastav as Chief Financial Officer, Effective March 29, 2024

March 14, 2024 at 08:17 am EDT

Innova Captab Limited announced that Mr. Gaurav Srivastava, Chief Financial Officer has tendered his resignation with effect from the close of business hours of March 29, 2024. Reason for change: Due to personal reason.

Latest news about Innova Captab Limited

Innova Captab Names CFO	Mar. 29	MT
Innova Captab Limited Appoints Lokesh Bhasin as the Chief Financial Officer, Effective March 30, 2024	Mar. 29	CI
Innova Captab Arm to Resume Operations at Raigad, India Facility Following Fire Incident	Mar. 21	MT
Innova Captab's CFO Resigns	Mar. 14	MT
Innova Captab Limited Announces Resignation of Gaurav Srivastav as Chief Financial Officer, Effective March 29, 2024	Mar. 14	CI
Innova Captab Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 13	CI
Innova Captab Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Jan. 18	CI
Innova Captab Limited has completed an IPO in the amount of INR 5.7 billion.	Dec. 26	CI

Chart Innova Captab Limited

Duration

Period

More charts

Company Profile

Innova Captab Ltd is an integrated pharmaceutical company. The Company is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It has presence across the pharmaceuticals value chain, including research and development, manufacturing, drug distribution and marketing and exports. Its business includes CDMO business, domestic branded generics business, and international branded generic product business. Its CDMO business provides research, product development and manufacturing services. Its branded generics business consists of the development, manufacture and distribution of generic formulation products, which are marketed and distributed in India under its own brand names through online and offline channels. Its generic drug products are also available online through various e-commerce pharmacy sites. It has developed a diversified branded generics product portfolio including Tablets, capsules, dry syrups, dry powder injection, ointments and liquid orals.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
INNOVA CAPTAB LIMITED	-13.39%	316M
ELI LILLY AND COMPANY	+31.06%	682B
NOVO NORDISK A/S	+30.35%	586B
JOHNSON & JOHNSON	-3.42%	364B
MERCK & CO., INC.	+18.02%	327B
ABBVIE INC.	+4.27%	285B
ASTRAZENECA PLC	+15.53%	240B
NOVARTIS AG	+10.16%	209B
ROCHE HOLDING AG	-8.14%	203B
AMGEN INC.	+8.12%	165B

Other Pharmaceuticals